|
GMEB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.133000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.132400E-01 |
| Normal-vs-Stage2 |
9.303600E-01 |
| Normal-vs-Stage3 |
2.343000E-01 |
| Normal-vs-Stage4 |
1.551040E-01 |
| Stage1-vs-Stage2 |
8.186600E-01 |
| Stage1-vs-Stage3 |
2.119200E-01 |
| Stage1-vs-Stage4 |
2.305400E-01 |
| Stage2-vs-Stage3 |
2.872200E-01 |
| Stage2-vs-Stage4 |
2.587600E-01 |
| Stage3-vs-Stage4 |
9.766400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.915800E-01 |
| Normal-vs-AfricanAmerican |
6.455000E-01 |
| Normal-vs-Asian |
6.961200E-01 |
| Caucasian-vs-AfricanAmerican |
9.866800E-01 |
| Caucasian-vs-Asian |
6.529200E-01 |
| AfricanAmerican-vs-Asian |
5.680800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.436000E-01 |
| Normal-vs-Female |
2.306000E-01 |
| Male-vs-Female |
2.308400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.767400E-01 |
| Normal-vs-Extreme_Weight |
9.741000E-01 |
| Normal-vs-Obese |
2.509000E-01 |
| Normal-vs-Extreme_Obese |
3.410200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.958600E-01 |
| Normal_Weight-vs-Obese |
3.795400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.235000E-01 |
| Extreme_Weight-vs-Obese |
2.433400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.643400E-01 |
| Obese-vs-Extreme_Obese |
1.864050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.227600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.485800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.650600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.874400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.494200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.106400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.184400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.598090E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.313900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.597000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.659600E-02 |
| Normal-VS-Type2 PRCC |
2.497600E-02 |
| Normal-VS-KIRP CIMP |
7.965600E-01 |
| Normal-VS-Unclassified PRCC |
2.329600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.25890000002293E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.558800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.376800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.628000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.552900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.723400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.903600E-01 |
| Normal-vs-N1 |
1.493450E-01 |
| Normal-vs-N2 |
1.357240E-01 |
| N0-vs-N1 |
3.271600E-02 |
| N0-vs-N2 |
3.680000E-01 |
| N1-vs-N2 |
9.874300E-02 |
|
|
